Proton beam therapy is an advanced form of external radiotherapy that uses high-energy proton beams instead of photon x-ray beams or electrons. Carefully measured doses of protons are delivered to the precise area needing treatment, using the latest IBA ProteusONE technology. This ensures that the delivery of proton beam therapy is highly accurate and prevents the risk of radiation reaching surrounding healthy tissue.
The radiotherapy treatment comes from an electrical machine called a ‘Linear accelerator’ and is directed as a beam to the part of the body that needs to be treated. Treatment is given daily over a period of days or weeks and you may hear people call these treatments ‘fractions’. They are just a fraction of your treatment dose and plan.
Chemotherapy at the Rutherford takes place in our modern therapy suites, consisting of up to ten treatment areas offering treatment for haematology/oncology patients requiring systemic anti-cancer therapy (SACT) and supportive care in an outpatient setting. The infusion therapy suites are available for patients undergoing treatment for breast, urology, upper and lower gastrointestinal cancers, and both malignant and non-malignant haematology disorders.
Dr Chris Tiplady has been a consultant haematologist since 2001 but was awarded his first medical qualification in 1992. His regular work involves treating and supporting people with a wide range of blood cancers: the myeloproliferative neoplasms (polycthaemia rubra vera and essential thrombocythaemia); myelodysplasia, lymphoma; chronic leukaemias and myeloma. He also treats patients with thrombosis, anaemia and haemochromatosis.
His research areas of interest include anaemia, pre-operative optimisation of anaemia and medical education.
British Society of Haematology
Royal College of Pathologists
Northern Regional Haematologists Group
Dr Chris Tiplady does not hold a share or financial interest in the Rutherford Cancer Centres or another Proton Partners International company.
Dr Chris Tiplady does not have a share or financial interest in equipment used at the Rutherford Cancer Centres or another Proton Partners International company.
Dr Chris Tiplady does hold any paid advisory role(s) at the Rutherford Cancer Centres or on behalf of Rutherford Cancer Centres or Proton Partners International.
Get in Touch
If you'd like to speak to us about any of the treatments we offer please don’t hesitate to get in touch. Call us on 0800 210 0402 or